Humana said its senior management team plans to reaffirm, at investor and analyst meetings from March 2, 2026 to March 31, its diluted earnings per share (EPS) outlook of at least $8.89 for the year ending December 31, 2026 (FY 2026).

1. 01

   Humana said its senior management team plans to reaffirm, at investor and analyst meetings from March 2, 2026 to March 31, its diluted earnings per share (EPS) outlook of at least $8.89 for the year ending December 31, 2026 (FY 2026).

2. 02

   The company said it also plans to reaffirm its FY 2026 adjusted earnings per share (Adjusted EPS) outlook of at least $9.00. It said this outlook is consistent with the outlook in its press release dated February 11, 2026.

3. 03

   Humana said its FY 2026 GAAP EPS outlook of at least $8.89, plus amortization of identifiable intangibles of 0.15 and adjusted for a cumulative net tax impact of (0.04), yields an Adjusted (non-GAAP) EPS outlook of at least $9.00.

4. 04

   The company said it does not expect changes to its FY 2026 Adjusted (non-GAAP) EPS outlook, but its FY 2026 GAAP EPS outlook may change due to its ongoing value creation and other strategic initiatives.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.